Hepatic artery thrombosis is a severe, early complication of orthotopic liver transplantation (OLT), with a reported mean incidence of 4–15% in adults; however, it remains unclear which patients are ...

Imaging findings of in situ pulmonary artery thrombosis associated with radiation therapy are different from acute pulmonary emboli and do not appear to embolize Leesburg, VA, October 9, ...

Thrombosis, or blood clot formation, can be life-threatening if ignored. Learn about its causes, early warning signs, and ...

Hepatic artery thrombosis (HAT) is the most common vascular complication after liver transplantation, occurring in 2–5% of liver transplant recipients. As such, HAT is a major cause of morbidity and ...

Today, October 13, is World Thrombosis Day, a global healthcare event observed annually to raise awareness about thrombosis, ...

An aortic thrombosis is a blood clot that forms in the aorta, the primary artery leading away from the heart. It is rare but is a medical emergency. An aortic thrombosis can disrupt the seamless flow ...

Thromboembolism occurs when a blood clot blocks a vein or artery, disrupting blood flow and potentially reaching vital organs ...

Last week at the New York Academy of Medicine four able investigators explained how coronary thrombosis, a common cause of heart failure, can be overcome and the victim’s life prolonged indefinitely.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

A stent thrombosis is a blood clot that forms within a coronary stent. It can be a complication of stent placement to open a narrowed artery. A coronary stent is a mesh tube that opens a narrowed or ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

PARIS--(BUSINESS WIRE)--Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced outstanding 12-month data for the DynamX™ Coronary Bioadaptor System, the first ...